Frontiers in Endocrinology · 2021 · 19 citations · 24 references
MedicineOncologyPathologyCancer ScreeningMetastasisNeoplasiaCancer StagingLymph Node MetastasisThyroid CancerLymph Node Metastasis AssessmentNodal Involvement AssessmentPrediction Model DevelopmentPrediction Model ValidationRegional Lymph Node MetastasisSkip MetastasisThyroid Cancer PathologyThyroid Carcinoma Metastasis To Lymph Nodes
Skip metastasis is a specific type of papillary thyroid cancer lymph node metastasis (LNM). The present study aimed to clarify the typical clinical characteristics of skip metastasis and optimize the prediction model, so as to provide a more individual treatment mode for skip metastasis. We retrospectively analyzed 1075 PTC patients with different lymph node metastasis statuses from two clinical centers. Comparisons have been made between patients with skip metastasis and other types of LNM. Univariate and multivariate analyses were performed to detect the risk factors for skip metastasis with negative LNM, and a nomogram for predicting skip metastasis was established. The rate of skip metastasis was 3.4% (37/1075). Compared with other types of LNM, significant differences showed in tumor size, upper portion location, thyroid capsular invasion, and ipsilateral nodular goiter with the central lymph node metastasis (CLNM) group, and in age and gender with the lateral lymph node metastasis (LLNM) group. Four variables were found to be significantly associated with skip metastasis and were used to construct the model: thyroid capsular invasion, multifocality, tumor size > 1 cm, and upper portion. The nomogram had good discrimination with a concordance index of 0.886 (95% confidence interval [CI], 0.823 to 0.948). In conclusion, the significant differences between skip metastasis and other types of LNM indicated that the lymph node drainage pathway of skip metastasis is different from either CLNM or LLNM. Furthermore, we established a nomogram for predicting risk of skip metastasis, which was able to effectively predict the potential risk of skip metastasis in patients without preoperative LNM clue.
24
Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer
Andreas Machens, Raoul Hinze, Oliver Thomusch et al. · World Journal of Surgery · 2001 · 509 citations
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma
Sameer Qubain, Shizuo Nakano, Masamichi Baba et al. · Surgery · 2002 · 253 citations
Genetic landscape of papillary thyroid carcinoma in the Chinese population
Jialong Liang, Wanshi Cai, Dongdong Feng et al. · The Journal of Pathology · 2017 · 142 citations